RichKid
PlanYourTrade > TradeYourPlan
- Joined
- 18 June 2004
- Posts
- 3,031
- Reactions
- 5
Burnham said:Well fell through 15.00 with eyes wide shut ( hit 14.91 actually) and promptly reversed to rocket back to a close of 15.19.
Stock for the brave this one .......
Burnham said:Congratulations - beautiful trade.
I bought this at $14.94 in January 2006. Sold it at a loss six months later.
It was a dog then, and as far as I'm concerned, it's a dog now.
SYDNEY, May 7 (Reuters) - Pathology staff at Australian medical services firm Symbion Health Ltd. SYB.AX are considering a bid for the pathology business following a takeover offer for Symbion by Healthscope Ltd. (ASX: HSP.ax) , the Australian Financial Review reported on Monday.
The paper said some 100 of Symbion's 150 pathology staff, unhappy with current working conditions and expecting worse under Healthscope, have formed a group to discuss their options, and have held talks about a bid for the business with a private equity firm.
Earlier this month, hospital operator Healthscope, in partnership with private equity firms Ironbridge Capital and Archer Capital, offered A$2.78 billion ($2.3 billion) in cash and shares for Symbion.
If the offer succeeds, Healthscope would acquire Symbion's pathology, medical centres and diagnostic imaging businesses, while Ironbridge and Archer would acquire the pharmacy distribution and consumer arms, which account for around a third of Symbion earnings.
"There is a consideration that dealing with Healthscope is worse than Symbion," the paper quoted an unidentified spokesperson for the pathologists as saying.
The staff are also considering leaving Symbion, the paper said, a claim rejected by Symbion Chief Executive Robert Cooke.
The paper also quoted an undentified analyst as saying that rival pathology company Sonic Healthcare Ltd. (ASX: SHL.ax) could benefit by taking on the disaffected Symbion staff.
So why did you buy it in the first place Julia?
I bought into SHL at 12.05 in Aug 06. It trades on quite high multiples (even for pathology/health related stocks), but has got a great reputation for their management (which has historically commanded a premium). So, a big safe stock for my portfolio and I wanted more exposure to health as i was overweight in resources.
Having said that, I am looking to exit after another 4 months (my plan for SHL was to hold for a year); but if it traces back below $14, I am out.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?